Page 12 - 南京医科大学学报自然科学版
P. 12
第43卷第5期
·594 · 南 京 医 科 大 学 学 报 2023年5月
[28] DANG L H,BETTEGOWDA C,HUSO D L,et al. Combi⁃ [J]. J Immunother Cancer,2020,8(2):e000973
nation bacteriolytic therapy for the treatment of experi⁃ [37] SHARAF L K,SHARMA M,CHANDEL D,et al. Prophy⁃
mental tumors[J]. Proc Natl Acad Sci U S A,2001,98 lactic intervention of probiotics(L.acidophilus,L.rhamno⁃
(26):15155-15160 sus GG)and celecoxib modulate Bax⁃mediated apoptosis
[29] ROBERTS N J,ZHANG L,JANKU F,et al. Intratumoral in 1,2 ⁃ dimethylhydrazine ⁃ induced experimental colon
injection of Clostridium novyi⁃NT spores induces antitu⁃ carcinogenesis[J]. BMC Cancer,2018,18(1):1111
mor responses[J]. Sci Transl Med,2014,6(249): [38] LEE S H,CHO S Y,YOON Y,et al. Bifidobacterium bifi⁃
249ra111 dum strains synergize with immune checkpoint inhibitors
[30] JANKU F,ZHANG H H,PEZESHKI A,et al. Intratumor⁃ to reduce tumour burden in mice[J]. Nat Microbiol,
al injection of Clostridium novyi ⁃ NT spores in patients 2021,6(3):277-288
with treatment⁃refractory advanced solid tumors[J]. Clin [39] DIZMAN N,MEZA L,BERGEROT P,et al. Nivolumab
Cancer Res,2021,27(1):96-106 plus ipilimumab with or without live bacterial supplemen⁃
[31] SUEZ J,ZMORA N,SEGAL E,et al. The pros,cons,and tation in metastatic renal cell carcinoma:a randomized
many unknowns of probiotics[J]. Nat Med,2019,25(5): phase 1 trial[J]. Nat Med,2022,28(4):704-712
716-729 [40] MULLARD A. Addressing cancer’s grand challenges[J].
[32] KIM S K,GUEVARRA R B,KIM Y T,et al. Role of pro⁃ Nat Rev Drug Discov,2020,19(12):825-826
biotics in human gut microbiome⁃associated diseases[J]. [41] ZHANG X,CHEN X,GUO Y,et al. Dual gate⁃controlled
J Microbiol Biotechnol,2019,29(9):1335-1340 therapeutics for overcoming bacterium⁃induced drug resis⁃
[33] KAEID SHARAF L,SHUKLA G. Probiotics(Lactobacillus tance and potentiating cancer immunotherapy[J]. Angew
acidophilus and Lactobacillus rhamnosus GG)in conjunc⁃ Chem Int Ed Engl,2021,60(25):14013-14021
tion with celecoxib(selective COX⁃2 inhibitor)modulated [42] HUANG X,PAN J,XU F,et al. Bacteria⁃based cancer im⁃
dmh⁃induced early experimental colon carcinogenesis[J]. munotherapy[J]. Adv Sci(Weinh),2021,8(7):2003572
Nutr Cancer,2018,70(6):946-955 [43] CHOWDHURY S,CASTRO S,COKER C,et al. Program⁃
[34] AGAH S,ALIZADEH A M,MOSAVI M,et al. More pro⁃ mable bacteria induce durable tumor regression and sys⁃
tection of Lactobacillus acidophilus than Bifidobacterium temic antitumor immunity[J]. Nat Med,2019,25(7):
bifidum probiotics on azoxymethane⁃induced mouse colon 1057-1063
cancer[J]. Probiotics Antimicrob Proteins,2019,11(3): [44] ZHOU S,GRAVEKAMP C,BERMUDES D,et al. Tumour⁃
857-864 targeting bacteria engineered to fight cancer[J]. Nat Rev
[35] GURBATRI C R,LIA I,VINCENT R,et al. Engineered Cancer,2018,18(12):727-743
probiotics for local tumor delivery of checkpoint blockade [45] WU L,LI L,LI S,et al. Macrophage⁃mediated tumor⁃tar⁃
nanobodies[J]. Sci Transl Med,2020,12(530): geted delivery of engineered Salmonella typhi murium
eaax0876 VNP20009 in anti⁃PD1 therapy against melanoma[J]. Ac⁃
[36] SHI L,SHENG J,CHEN G,et al. Combining IL⁃2⁃based ta Pharm Sin B,2022,12(10):3952-3971
immunotherapy with commensal probiotics produces en⁃ [收稿日期] 2023-02-17
hanced antitumor immune response and tumor clearance (本文编辑:唐 震)